CLPT Clearpoint Neuro Inc
Company Analysis
Latest News
Clearpoint Neuro's Big Bet on Gene Therapy Delivery Takes a Hit — But Is the Selloff Overdone?
Shares of Clearpoint Neuro cratered 15.8% to $12.88 Tuesday morning after partner uniQure reported that its Huntington's disease gene therapy showed a weaker...
🔴 Clearpoint Neuro is trading 15.84% down now at $12.88 after AMT-130 missed statistical significance
Clearpoint Neuro is trading 15.84% down at $12.88 after a September 29 report linked the selloff to disappointing uniQure AMT-130 results. - The Huntington’s...
🔴 Clearpoint Neuro is trading 27.86% down in pre-market
Clearpoint Neuro is trading 27.86% down at $11.04 in pre-market, based on the supplied pre-market price, after closing at $15.31 on September 28; no reported...
🔴 Clearpoint Neuro is trading 5% down today amid rising crude oil and Treasury yields
Clearpoint Neuro is trading 5% down at $15.00 amid broader risk-off trading on September 23, 2026. - The S&P 500 was down 0.73% and Nasdaq Composite down...
Stifel Says Clearpoint Neuro Is Worth 42% More — But Can a Tiny MedTech Company Really Ride the Gene-Therapy Wave?
Stifel Doubles Down on Clearpoint Neuro at $22 — Can a $470M Company Really Capture the Gene-Therapy Delivery Market? Shares of Clearpoint Neuro surged 11.1%...
🟢 Clearpoint Neuro is trading 11.1% up today after Stifel reiterated Buy rating and $22 target
Clearpoint Neuro is trading 11.1% higher at $15.52 after Stifel reiterated its Buy rating and $22 price target, citing the company’s cell- and gene-therapy...
🟢 Clearpoint Neuro is trading 5.6% up today amid Stifel's reiterated $22 target
Clearpoint Neuro is trading at $14.75 (+5.58%), following steady gains from $13.46 on September 14 to $13.97 on September 21. - No fresh company-specific...
🟢 Clearpoint Neuro is trading 5.83% up in pre-market with no fresh company-specific announcement identified
Clearpoint Neuro is trading at $14.27, up +5.83% before September 11, 2026, with no fresh company-specific announcement identified. - S&P 500 futures are up...
🟢 Clearpoint Neuro is trading 5% up today on healthcare-sector strength
Clearpoint Neuro is trading 5.1% up at $15.66, apparently supported by healthcare-sector strength rather than a company-specific catalyst. - No fresh...
🟢 Clearpoint Neuro is trading 7.58% up in pre-market despite no new company-specific catalyst
Clearpoint Neuro is trading 7.58% up at $16.03 after no new company-specific catalyst was identified for September 2, 2026. - The latest official...
🟢 Clearpoint Neuro is trading 10.75% up today — no clear company-specific catalyst identified
Clearpoint Neuro is trading 10.75% up at $16.80, with no clear company-specific catalyst identified for August 25, 2026. - The latest listed company release...
🟢 Clearpoint Neuro is trading 6% up today
Clearpoint Neuro is trading at $16.10, up 6.13%, with no clear catalyst identified. - No new company-specific announcement dated August 25, 2026 was...
Clearpoint Neuro's Revenue Miss and Guidance Cut Drain Cash and Confidence — Can a $500 Million Dream Survive a $29 Million Reality?
Shares of Clearpoint Neuro sank 12.3% to $14.00 on August 20 as investors continued to punish the medical-device maker for second-quarter results that fell...
🔴 Clearpoint Neuro is trading 12.3% down in pre-market after Q2 earnings miss and revised 2026 guidance
Clearpoint Neuro is trading 12.3% down now at $14.00 after renewed attention to its second-quarter results and outlook. - Q2 revenue was $10.9 million, while...
🟢 Clearpoint Neuro rises 5.3% — Healthcare Stocks Surge on Strong Earnings Outlook and Investor Rotation
With Healthcare (XLV) up 3.2%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector experienced a significant...
🟢 Clearpoint Neuro is trading 6.4% up today on healthcare sector strength
Clearpoint Neuro is trading 6.4% up at $14.25 after recovering from the August 3 earnings-driven decline alongside broader healthcare strength. - The...
🟢 Clearpoint Neuro is trading 5.7% up in pre-market after August 3 earnings selloff
Clearpoint Neuro is trading 5.7% up at $14.15, reflecting broader healthcare strength and a rebound following its August 3 earnings selloff. - Healthcare...
Clearpoint Neuro's Cash Is Burning Fast — Can a $500 Million Dream Survive a 20% Stock Crash?
Shares of Clearpoint Neuro cratered 20.2% to $12.28 after the brain-surgery device maker reported second-quarter results that exposed a widening gap between...
🔴 Clearpoint Neuro is trading 19% down today after cutting FY2026 guidance and posting a wider-than-expected loss
Clearpoint Neuro is trading 19% down at $12.41 after its August 3 earnings report revealed a wider-than-expected quarterly loss and a downward revision to...
🔴 Clearpoint Neuro is trading 15.5% down today after cutting full-year revenue guidance and reporting a wider net loss
Clearpoint Neuro is trading at $13.00 (15.5% down) after its second-quarter earnings disappointed and management lowered full-year 2026 revenue guidance. •...